[HTML] nih.gov

COVID-19 pandemic and its recovery time of patients in India: A pilot study

MP Barman, T Rahman, K Bora, C Borgohain - Diabetes & Metabolic …, 2020 - Elsevier
Background and aims Covid-19 virus started from Wuhan, China and has brought the world
down to its knees. It has catapulted as a venomous global phenomenon. This study focuses …
被引用次数：107 相关文章 所有 8 个版本
[HTML] nih.gov

Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh

F Akter, A Mannan, HMH Mehedi, MA Rob… - Diabetes & Metabolic …, 2020 - Elsevier
Background and aims This study investigated the clinical manifestations, outcomes and long-
term complications of COVID-19 inpatients in southern part of Bangladesh while …
被引用次数：98 相关文章 所有 5 个版本

Differences between first wave and second wave of COVID-19 in India

VK Jain, KP Iyengar, R Vaishya - Diabetes & metabolic syndrome, 2021 - ncbi.nlm.nih.gov
The recent wave of corona virus is spreading like a 'tsunami'in India. As on April 23, 2021,
the COVID-19 cases have crossed the 15.9 million, with 1, 85,000 deaths. The 2nd wave is …
被引用次数：182 相关文章 所有 4 个版本
[HTML] nih.gov

Differential mortality in COVID-19 patients from India and western countries

VK Jain, K Iyengar, A Vaish, R Vaishya - Diabetes & Metabolic Syndrome …, 2020 - Elsevier
Background and aims COVID-19 disease has been associated with disproportionate
mortality amongst world population. We try to elucidate various reasons for lower mortality …
被引用次数：104 相关文章 所有 4 个版本
[PDF] springer.com

Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study

SA SeyedAlinaghi, L Abbasian, M Solduzian… - European Journal of …, 2021 - Springer
Background The clinical course of COVID-19 may vary significantly. The presence of
comorbidities prolongs the recovery time. The recovery in patients with mild-to-moderate …
被引用次数：56 相关文章 所有 16 个版本
[HTML] nih.gov

COVID-19 outbreak in Iraqi Kurdistan: The first report characterizing epidemiological, clinical, laboratory, and radiological findings of the disease

MA Merza, AAH Al Mezori, HM Mohammed… - Diabetes & Metabolic …, 2020 - Elsevier
Abstract Introduction On March 11, 2020, the novel coronavirus was declared a global
pandemic. The disease was named COVID-19 standing for coronavirus disease 2019. The …
被引用次数：64 相关文章 所有 7 个版本
[HTML] nih.gov

Risk factors for mortality among COVID-19 patients

O Albitar, R Ballouze, JP Ooi, SMS Ghadzi - Diabetes research and clinical …, 2020 - Elsevier
Aims COVID-19 is a current global pandemic. However, comprehensive global data
analyses for its mortality risk factors are lacking. The current investigation aimed to assess …
被引用次数：317 相关文章 所有 11 个版本
[HTML] nih.gov

[HTML][HTML] Clinical considerations for patients with diabetes in times of COVID-19 epidemic

R Gupta, A Ghosh, AK Singh, A Misra - Diabetes & metabolic …, 2020 - ncbi.nlm.nih.gov
COVID-19 (Coronavirus Disease-2019), a disease caused by the coronavirus SARS-CoV-2
(Severe Acute Respiratory Syndrome-Coronavirus-2), has emerged as a rapidly spreading …
被引用次数：716 相关文章 所有 10 个版本
[HTML] nih.gov

Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases-March 14th 2020)

S Ghosal, S Sengupta, M Majumder, B Sinha - Diabetes & Metabolic …, 2020 - Elsevier
Abstract Introduction and Aims: No valid treatment or preventative strategy has evolved till
date to counter the SARS CoV 2 (Novel Coronavirus) epidemic that originated in China in …
被引用次数：154 相关文章 所有 6 个版本
[PDF] frontiersin.org

Clinical characteristics and the long-term post-recovery manifestations of the COVID-19 patients—A prospective multicenter cross-sectional study

ATM Mohiuddin Chowdhury, MR Karim, MA Ali… - Frontiers in …, 2021 - frontiersin.org
Objective: Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection is a global issue. In addition to managing acute …
被引用次数：51 相关文章 所有 10 个版本